MicroRNAs as biomarkers for CNS cancer and other disorders

Enrico De Smaele, Elisabetta Ferretti, Alberto Gulino

Research output: Contribution to journalArticle

87 Citations (Scopus)

Abstract

The use of miRNAs as biomarkers has gained growing interest in the last few years. Their role in regulating a great variety of targets and, as a consequence, multiple pathways, makes their use in diagnostics a powerful tool to be exploited for early detection of disease, risk assessment and prognosis and for the design of innovative therapeutic strategies. While still not fully validated, profiling of blood cells, exosomes or body fluid miRNAs would represent a tremendous and promising advance in non-invasive diagnostics of CNS disorders. A major challenge is represented by technological aspects of miRNA detection and discovery aiming to genome-wide high throughput, sensitive and accurate analysis. Although there is much to be learned in the field, this review will highlight the potential role of miRNA as a new class of biomarkers in several CNS disorders, including neurodegenerative diseases such as Alzheimer, Huntington and Parkinson diseases, schizophrenia and autism as well as different types of cancer (e.g. gliomas and medulloblastomas).

Original languageEnglish
Pages (from-to)100-111
Number of pages12
JournalBrain Research
Volume1338
DOIs
Publication statusPublished - Jun 18 2010

Fingerprint

Tumor Biomarkers
MicroRNAs
Biomarkers
Exosomes
Medulloblastoma
Huntington Disease
Body Fluids
Autistic Disorder
Glioma
Neurodegenerative Diseases
Parkinson Disease
Early Diagnosis
Blood Cells
Schizophrenia
Alzheimer Disease
Genome
Neoplasms
Therapeutics

Keywords

  • Glioma
  • Medulloblastoma
  • miRNA
  • Neurodegeneration
  • Tumors

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology
  • Developmental Biology
  • Molecular Biology

Cite this

MicroRNAs as biomarkers for CNS cancer and other disorders. / De Smaele, Enrico; Ferretti, Elisabetta; Gulino, Alberto.

In: Brain Research, Vol. 1338, 18.06.2010, p. 100-111.

Research output: Contribution to journalArticle

De Smaele, Enrico ; Ferretti, Elisabetta ; Gulino, Alberto. / MicroRNAs as biomarkers for CNS cancer and other disorders. In: Brain Research. 2010 ; Vol. 1338. pp. 100-111.
@article{2924b4c146434d13aa100f540039cbcd,
title = "MicroRNAs as biomarkers for CNS cancer and other disorders",
abstract = "The use of miRNAs as biomarkers has gained growing interest in the last few years. Their role in regulating a great variety of targets and, as a consequence, multiple pathways, makes their use in diagnostics a powerful tool to be exploited for early detection of disease, risk assessment and prognosis and for the design of innovative therapeutic strategies. While still not fully validated, profiling of blood cells, exosomes or body fluid miRNAs would represent a tremendous and promising advance in non-invasive diagnostics of CNS disorders. A major challenge is represented by technological aspects of miRNA detection and discovery aiming to genome-wide high throughput, sensitive and accurate analysis. Although there is much to be learned in the field, this review will highlight the potential role of miRNA as a new class of biomarkers in several CNS disorders, including neurodegenerative diseases such as Alzheimer, Huntington and Parkinson diseases, schizophrenia and autism as well as different types of cancer (e.g. gliomas and medulloblastomas).",
keywords = "Glioma, Medulloblastoma, miRNA, Neurodegeneration, Tumors",
author = "{De Smaele}, Enrico and Elisabetta Ferretti and Alberto Gulino",
year = "2010",
month = "6",
day = "18",
doi = "10.1016/j.brainres.2010.03.103",
language = "English",
volume = "1338",
pages = "100--111",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",

}

TY - JOUR

T1 - MicroRNAs as biomarkers for CNS cancer and other disorders

AU - De Smaele, Enrico

AU - Ferretti, Elisabetta

AU - Gulino, Alberto

PY - 2010/6/18

Y1 - 2010/6/18

N2 - The use of miRNAs as biomarkers has gained growing interest in the last few years. Their role in regulating a great variety of targets and, as a consequence, multiple pathways, makes their use in diagnostics a powerful tool to be exploited for early detection of disease, risk assessment and prognosis and for the design of innovative therapeutic strategies. While still not fully validated, profiling of blood cells, exosomes or body fluid miRNAs would represent a tremendous and promising advance in non-invasive diagnostics of CNS disorders. A major challenge is represented by technological aspects of miRNA detection and discovery aiming to genome-wide high throughput, sensitive and accurate analysis. Although there is much to be learned in the field, this review will highlight the potential role of miRNA as a new class of biomarkers in several CNS disorders, including neurodegenerative diseases such as Alzheimer, Huntington and Parkinson diseases, schizophrenia and autism as well as different types of cancer (e.g. gliomas and medulloblastomas).

AB - The use of miRNAs as biomarkers has gained growing interest in the last few years. Their role in regulating a great variety of targets and, as a consequence, multiple pathways, makes their use in diagnostics a powerful tool to be exploited for early detection of disease, risk assessment and prognosis and for the design of innovative therapeutic strategies. While still not fully validated, profiling of blood cells, exosomes or body fluid miRNAs would represent a tremendous and promising advance in non-invasive diagnostics of CNS disorders. A major challenge is represented by technological aspects of miRNA detection and discovery aiming to genome-wide high throughput, sensitive and accurate analysis. Although there is much to be learned in the field, this review will highlight the potential role of miRNA as a new class of biomarkers in several CNS disorders, including neurodegenerative diseases such as Alzheimer, Huntington and Parkinson diseases, schizophrenia and autism as well as different types of cancer (e.g. gliomas and medulloblastomas).

KW - Glioma

KW - Medulloblastoma

KW - miRNA

KW - Neurodegeneration

KW - Tumors

UR - http://www.scopus.com/inward/record.url?scp=77952583639&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952583639&partnerID=8YFLogxK

U2 - 10.1016/j.brainres.2010.03.103

DO - 10.1016/j.brainres.2010.03.103

M3 - Article

C2 - 20380821

AN - SCOPUS:77952583639

VL - 1338

SP - 100

EP - 111

JO - Brain Research

JF - Brain Research

SN - 0006-8993

ER -